This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06855/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB06855/identifier/pubchem-compound/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB06855/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06855/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB06855/identifier/chemspider/

Statements

Subject Item
n2:DB06855
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB06855 n12:DB06855
dcterms:title
6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
adms:identifier
n4:6102526 n7:20120240 n8:DB06855 n13:99443326 n14:133
n5:IUPAC-Name
n6:271B587A-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5880-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B587F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B587C-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B587D-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B587E-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5878-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5876-363D-11E5-9242-09173F13E4C5 n6:271B5879-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5877-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5886-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5887-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5881-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5882-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5884-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5883-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5885-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B588C-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B588E-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B588F-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B588B-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B588A-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B588D-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B587B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5888-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5889-363D-11E5-9242-09173F13E4C5